Scholar Rock Holding SRRK
NASDAQ SRRK
$46.81 +0.65 (+1.41%)
At close: Oct 2, 2026 · 4:00 PM EDT

Scholar Rock Holding (SRRK) Depreciation & Amortization (CF) (2017 - 2026)

Updated

Scholar Rock Holding's Depreciation & Amortization (CF) came in at $297,000 for Q2 2026, down 28.8% from $417,000 a year earlier and down 11.3% from the prior quarter.

Analysis

Scholar Rock Holding (SRRK) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Scholar Rock Holding reported Depreciation & Amortization (CF) of $1.52 million, down 7.8% year-over-year; for FY2025, it was $1.7 million, down 12.2% from FY2024.

  • Depreciation & Amortization (CF) has declined in each of the last three years, though with a five-year compound annual growth rate of 2.5% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $1.94 million in FY2024 (-31.9%), $2.84 million in FY2023 (-5.2%), $3 million in FY2022 (+14.2%) and $2.63 million in FY2021 (+75.1%).
  • The Q2 2026 figure represents the lowest quarterly Depreciation & Amortization (CF) since Q1 2019.
  • Year-over-year, Depreciation & Amortization (CF) increased in 1 of the last eight quarters, with an average decline of 19.9%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2021 (growth of 121.6%), and the weakest in Q4 2024 (a decline of 41.2%).
  • Business Quant data shows SRRK's Depreciation & Amortization (CF) at $335,000 (Q1 2026), $467,000 (Q4 2025) and $423,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Scholar Rock Holding 5.61 Bn 5.61 Bn - 297,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 297,000.00
Mar 31, 2026 335,000.00
Dec 31, 2025 467,000.00
Sep 30, 2025 423,000.00
Jun 30, 2025 417,000.00
Mar 31, 2025 393,000.00
Dec 31, 2024 395,000.00
Sep 30, 2024 446,000.00
Jun 30, 2024 498,000.00
Mar 31, 2024 598,000.00
Dec 31, 2023 672,000.00
Sep 30, 2023 708,000.00
Jun 30, 2023 731,000.00
Mar 31, 2023 733,000.00
Dec 31, 2022 763,000.00
Sep 30, 2022 744,000.00
Jun 30, 2022 744,000.00
Mar 31, 2022 749,000.00
Dec 31, 2021 727,000.00
Sep 30, 2021 673,000.00
API Access

Scholar Rock Holding Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SRRK&period=max&api_key=YOUR_API_KEY